• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC SAFETY INFUSION SET 19G X 1 IN WITH Y-SITE; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC SAFETY INFUSION SET 19G X 1 IN WITH Y-SITE; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Device Problems Crack (1135); Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/08/2023
Event Type  malfunction  
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The date of event was not provided by the complainant/reporter, the date reflected in this report is the date bd became aware of the event.The manufacturer has received the sample and is pending evaluation.Results are expected soon.
 
Event Description
It was reported that there was a leak, around the y-site end area of the port tubing.Patient receiving immunotherapy and completed it, staff noticed leakage at the site prior to connecting to pump.Changed the entire port needle and no further leakage noted.Received medication from pump.No other information provided.Additional information received (b)(6) 2023: it was reported there is interruption of administration of medication/cause a clinically significant delay in medication that negatively impacted the patient.Patient did not receive all prescribed chemo for cancer regimen, patient was exposed to the chemo.Chemo exposure, no harm.
 
Event Description
It was reported that there was a leak, around the y-site end area of the port tubing.Patient receiving immunotherapy and completed it, staff noticed leakage at the site prior to connecting to pump.Changed the entire port needle and no further leakage noted.Received medication from pump.No other information provided.Additional information received 8/21/2023: it was reported there is interruption of administration of medication/cause a clinically significant delay in medication that negatively impacted the patient.Patient did not receive all prescribed chemo for cancer regimen, patient was exposed to the chemo.Chemo exposure, no harm.
 
Manufacturer Narrative
The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.Based on a review of applicable information, the following was concluded: the complaint of a crack in the y-site was confirmed as supplier related.The returned sample was found to exhibit the same features as a known issue.The returned product was a 19g x 1¿ powerloc safety infusion set.The y-site luer adaptor contained a longitudinal crack traversed from the orifice of the connector to the mold indicator.The crack in the y-site luer adaptor leaked when the sample was flushed.This event was likely related to a known supplier related issue.This complaint will be recorded for future trending and monitoring purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC SAFETY INFUSION SET 19G X 1 IN WITH Y-SITE
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city UT 84116
Manufacturer Contact
suedabba mahboobi
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key17626975
MDR Text Key321992419
Report Number3006260740-2023-03705
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741047893
UDI-Public(01)00801741047893
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K060812
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/18/2023
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue Number0671910
Device Lot NumberASGYFC003
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/24/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/08/2023
Initial Date FDA Received08/25/2023
Supplement Dates Manufacturer Received12/18/2023
Supplement Dates FDA Received12/26/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age73 YR
Patient SexFemale
-
-